Epstein Secrets

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

t decided yet whether to appeal the decision, a spokeswoman in the U.S. attorney's office in the Eastern District of California said in a statement, the Sacramento Bee reported. "We are in the process of reviewing the district court decision and assessing what steps, if any, should be taken and considering all our

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

t decided yet whether to appeal the decision, a spokeswoman in the U.S. attorney's office in the Eastern District of California said in a statement, the Sacramento Bee reported. "We are in the process of reviewing the district court decision and assessing what steps, if any, should be taken and considering all our

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. EFTA00085695 The office also said Collins may have broken House ethics rules by persuad

t decided yet whether to appeal the decision, a spokeswoman in the U.S. attorney's office in the Eastern District of California said in a statement, the Sacramento Bee reported. "We are in the process of reviewing the district court decision and assessing what steps, if any, should be taken and considering all our

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

t decided yet whether to appeal the decision, a spokeswoman in the U.S. attorney's office in the Eastern District of California said in a statement, the Sacramento Bee reported. "We are in the process of reviewing the district court decision and assessing what steps, if any, should be taken and considering all our

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

t decided yet whether to appeal the decision, a spokeswoman in the U.S. attorney's office in the Eastern District of California said in a statement, the Sacramento Bee reported. "We are in the process of reviewing the district court decision and assessing what steps, if any, should be taken and considering all our